Chromosome 2q37 deletion: clinical and molecular aspects - PubMed (original) (raw)
Review
. 2007 Nov 15;145C(4):357-71.
doi: 10.1002/ajmg.c.30153.
Affiliations
- PMID: 17910077
- DOI: 10.1002/ajmg.c.30153
Review
Chromosome 2q37 deletion: clinical and molecular aspects
Rena E Falk et al. Am J Med Genet C Semin Med Genet. 2007.
Abstract
Terminal deletions of chromosome 2 with breakpoints at or within band 2q37, ranging from visible abnormalities to cryptic, subtelomeric deletions, have been recognized with increasing frequency among children with mild-moderate mental retardation, characteristic facial appearance, and behavioral manifestations which often place them on the autism spectrum. The stereotypic facial characteristics include prominent forehead, thin, highly arched eyebrows, depressed nasal bridge, full cheeks, deficient nasal alae and prominent columella, thin upper lip, and various minor anomalies of the pinnae. Abnormal nipples, including inverted nipples, have been reported in a number of cases. CNS, ocular, cardiac, gastrointestinal, renal, and other GU anomalies have been noted in nearly one-third of patients. Of note, coarctation or hypoplasia of the aorta has been described in several affected children. Wilms tumor, renal dysplasia, and tracheomalacia have been reported only with the most proximal breakpoint at band 2q37.1 while a range of GI anomalies, pyloric stenosis, and diaphragmatic defects have been reported with breakpoints throughout the region. A subset of patients with the most distal deletion present phenotypic features which mimic Albright hereditary osteodystrophy (AHO). In addition to the AHO-like phenotype, later onset findings include seizures and cystic kidneys. Timely diagnosis of this recognizable syndrome provides a basis for genetic counseling, appropriate surveillance, and intervention, and avoids unnecessary and expensive diagnostic testing.
(c) 2007 Wiley-Liss, Inc.
Similar articles
- Deletion 2q37.3 and autism: molecular cytogenetic mapping of the candidate region for autistic disorder.
Lukusa T, Vermeesch JR, Holvoet M, Fryns JP, Devriendt K. Lukusa T, et al. Genet Couns. 2004;15(3):293-301. Genet Couns. 2004. PMID: 15517821 - Molecular delineation of deletions on 2q37.3 in three cases with an Albright hereditary osteodystrophy-like phenotype.
Shrimpton AE, Braddock BR, Thomson LL, Stein CK, Hoo JJ. Shrimpton AE, et al. Clin Genet. 2004 Dec;66(6):537-44. doi: 10.1111/j.1399-0004.2004.00363.x. Clin Genet. 2004. PMID: 15521982 - Further delineation of deletion 1p36 syndrome in 60 patients: a recognizable phenotype and common cause of developmental delay and mental retardation.
Battaglia A, Hoyme HE, Dallapiccola B, Zackai E, Hudgins L, McDonald-McGinn D, Bahi-Buisson N, Romano C, Williams CA, Brailey LL, Zuberi SM, Carey JC. Battaglia A, et al. Pediatrics. 2008 Feb;121(2):404-10. doi: 10.1542/peds.2007-0929. Pediatrics. 2008. PMID: 18245432 - 11q- syndrome: three cases and a review of the literature.
Leegte B, Kerstjens-Frederikse WS, Deelstra K, Begeer JH, van Essen AJ. Leegte B, et al. Genet Couns. 1999;10(3):305-13. Genet Couns. 1999. PMID: 10546104 Review. - Phenotypic and molecular assessment of seven patients with 6p25 deletion syndrome: relevance to ocular dysgenesis and hearing impairment.
Gould DB, Jaafar MS, Addison MK, Munier F, Ritch R, MacDonald IM, Walter MA. Gould DB, et al. BMC Med Genet. 2004 Jun 25;5:17. doi: 10.1186/1471-2350-5-17. BMC Med Genet. 2004. PMID: 15219231 Free PMC article. Review.
Cited by
- Testicular sex cord-stromal tumor in a boy with 2q37 deletion syndrome.
Sakai Y, Souzaki R, Yamamoto H, Matsushita Y, Nagata H, Ishizaki Y, Torisu H, Oda Y, Taguchi T, Shaw CA, Hara T. Sakai Y, et al. BMC Med Genomics. 2014 Apr 22;7:19. doi: 10.1186/1755-8794-7-19. BMC Med Genomics. 2014. PMID: 24755370 Free PMC article. - Phenotypic variant of Brachydactyly-mental retardation syndrome in a family with an inherited interstitial 2q37.3 microdeletion including HDAC4.
Villavicencio-Lorini P, Klopocki E, Trimborn M, Koll R, Mundlos S, Horn D. Villavicencio-Lorini P, et al. Eur J Hum Genet. 2013 Jul;21(7):743-8. doi: 10.1038/ejhg.2012.240. Epub 2012 Nov 28. Eur J Hum Genet. 2013. PMID: 23188045 Free PMC article. - 2q37 Deletions in Patients With an Albright Hereditary Osteodystrophy Phenotype and PTH Resistance.
Elli FM, de Sanctis L, Madeo B, Maffini MA, Bordogna P, Pirelli A, Arosio M, Mantovani G. Elli FM, et al. Front Endocrinol (Lausanne). 2019 Aug 29;10:604. doi: 10.3389/fendo.2019.00604. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31555217 Free PMC article. - 2q37 Deletion syndrome confirmed by high-resolution cytogenetic analysis.
Cho EK, Kim J, Yang A, Cho SY, Jin DK. Cho EK, et al. Ann Pediatr Endocrinol Metab. 2017 Jun;22(2):129-132. doi: 10.6065/apem.2017.22.2.129. Epub 2017 Jun 28. Ann Pediatr Endocrinol Metab. 2017. PMID: 28690993 Free PMC article. - Pseudohypoparathyroidism and Gsα-cAMP-linked disorders: current view and open issues.
Mantovani G, Spada A, Elli FM. Mantovani G, et al. Nat Rev Endocrinol. 2016 Jun;12(6):347-56. doi: 10.1038/nrendo.2016.52. Epub 2016 Apr 22. Nat Rev Endocrinol. 2016. PMID: 27109785 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical